Very low prevalence of endophthalmitis in very low birthweight infants who survive candidemia

Journal of Perinatology

Volumn 25, Issue 6, 2005, Pages 408-411

  Fisher, Randall G ^a   Karlowicz, Mitchell Gary ^a   Lall Trail, Joel ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ARTICLE; BIRTH WEIGHT; CANDIDIASIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPHTHALMITIS; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; RETROLENTAL FIBROPLASIA; SCREENING TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; VERY LOW BIRTH WEIGHT;

CANDIDIASIS; ENDOPHTHALMITIS; FEMALE; FUNGEMIA; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; PREVALENCE;

EID: 20844432906     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211300     Document Type: Article

References (21)

1. Stoll BJ, Hansen N, Fanaroff AA. Late-onset sepsis in very low birth weight neonates: the experience of the NIGHD Neonatal Research Network. Pediatrics 2002;110:285-91.
2. Parke II DW, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology 1982;89:789-96.
3. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 1989;149:2226-8.
4. Baley JE, Annable WL, Kliegman RM. Candida endophthalmitis in the premature infant. J Pediatr 1981;98:458-61.
5. Baley JE, Ellis FJ. Neonatal candidiasis: ophthalmologic infection. Semin Perinatol 2003;27:401-5.
6. Noyola DE, Fernandez M, Moylett EH, Baker GJ. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 2001;32:1018-23.
7. Benjamin DKJ, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112:634-40.
8. Chapman RL, Faix RG. Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J 2000;19:822-7.
9. Karlowicz MG, Giannone PJ, Pestian J, Morrow AL, Shults J. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (≤ 1000g) neonates? Pediatrics 2000;105:1036-40.
10. American Academy of Pediatrics, American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2001;108:809-11.
11. Young TE. Topical mydriatics: the adverse effects of screening examinations for retinopathy of prematurity. NeoReviews 2003;4:e163-6.
12. Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol 1996;80:425-8.
13. Bates J, Burnsteine RA. Consequences of retinopathy of prematurity examinations. Case report. Arch Ophthalmol 1987;105:618-9.
14. Makhoul IR, Kassis T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics 2001;107:61-6.
15. Weems JJ. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992;14:756-66.
16. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-8.
17. Faix RG. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatric Infect Dis J 1992;11:88-93.
18. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89.
19. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
20. Rex JH, Pappas PG, Karchmer AW. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in non neutropenic subjects. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 2001;36:1221-8.
21. Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002;347:2020-9.